Definitive Healthcare (NASDAQ:DH) Releases Q1 2025 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.020-0.020 for the period, compared to the consensus estimate of 0.070. The company issued revenue guidance of $55.5 million-$57.0 million, compared to the consensus revenue estimate of $60.0 million. Definitive Healthcare also updated its FY 2025 guidance to 0.190-0.220 EPS.

Wall Street Analysts Forecast Growth

DH has been the topic of several research reports. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Barclays reiterated an “underweight” rating and set a $4.00 target price on shares of Definitive Healthcare in a research note on Monday, January 13th. Finally, Stephens initiated coverage on Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $5.72.

Definitive Healthcare Stock Performance

DH traded down $0.18 during trading on Thursday, reaching $4.92. The company’s stock had a trading volume of 671,754 shares, compared to its average volume of 764,583. The company has a market capitalization of $568.37 million, a price-to-earnings ratio of -1.59, a price-to-earnings-growth ratio of 4.06 and a beta of 1.45. The company’s fifty day moving average price is $4.63 and its 200-day moving average price is $4.47. Definitive Healthcare has a 52-week low of $3.19 and a 52-week high of $10.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Insider Activity at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares in the company, valued at $2,039,001. This trade represents a 9.40 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 14.84% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.